HOME > TOP STORIES
TOP STORIES
-
REGULATORY MHLW Approves Amgen/Astellas’ Evenity, Gilead Sciences’ Epclusa and More
January 9, 2019
-
BUSINESS Takeda Completes £46 Billion Shire Acquisition
January 8, 2019
-
REGULATORY MHLW to Follow Up on Drug Makers’ Efforts to Observe New Detailing Guidelines
January 7, 2019
-
BUSINESS Can Daiichi Sankyo Take Big Leap in Oncology with 3 FDA Nods in FY2019?
January 4, 2019
-
BUSINESS Reata Developing Sakigake Designated DKD Drug for Alport Syndrome in Japan
December 28, 2018
-
BUSINESS Biogen Japan Set to “Make Impossible Possible” in Next 5 Years, Double Neuroscience Pipeline
December 27, 2018
-
TRENDS Top 10 PHARMA JAPAN Stories in 2018
December 26, 2018
-
BUSINESS Some Drug Makers Stop Distributing 2019 Calendars with Revised JPMA Code of Practice Set to Take Effect in January
December 25, 2018
-
REGULATORY MHLW OKs Add’l Indications for Keytruda, Tecentriq, Hemlibra, and More
December 25, 2018
-
REGULATORY After Settling on October 2019 Re-Pricing, When Will Govt Reveal New Drug Prices?
December 21, 2018
-
REGULATORY PhRMA, EFPIA Pitch Enhanced Appraisal Model for Japan HTA Plan; Chuikyo Reps Acknowledge ICER Limitations
December 20, 2018
-
REGULATORY Govt to Pare Drug Prices by 2.4% in October 2019 Ad-Hoc Re-Pricing
December 19, 2018
-
BUSINESS Takeda Likely to Make NYSE Debut on Christmas Eve
December 19, 2018
-
REGULATORY Ministers Agree on Ad-Hoc Drug Re-Pricing in October 2019, 29 Billion Yen Saving in State Coffers
December 18, 2018
-
COMMENTARY LDP Draws Up Tax Reform Outline, Revamps Credits for R&D Expenses
December 17, 2018
-
BUSINESS Astellas Makes Full Inroads into I/O Arena with Potenza Buyout
December 17, 2018
-
BUSINESS Lundbeck Japan to Quadruple Workforce by Next Summer, Eyes Vortioxetine Launch: Chief
December 14, 2018
-
BUSINESS Astellas CEO Sees Cell Therapy Biz Model Established by “around 2030”
December 14, 2018
-
REGULATORY Govt to Tap R&D Tax Credit System to Push Research on Pediatric Use, Superbug Fight
December 13, 2018
-
REGULATORY Chuikyo Adopts Outline of 2019 Drug Price Revision for Sales Tax Hike
December 13, 2018
ページ
We had just gotten off a call with a client in Europe, and we’d received a bit of an earful. “Philip,” the client pressed, “what can this candidate bring to us? We know what he does, but what has he…
